Vpr Enhances HIV-1 Env Processing and Virion Infectivity in Macrophages by Modulating TET2-Dependent IFITM3 Expression
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
How Vpr enhances HIV-1 replication in macrophages is still unclear. We report here that Vpr enhanced HIV-1 Env processing during the first round of HIV-1 replication, resulting in virions with higher Env incorporation and viral infectivity. These higher-quality viral particles contributed to elevated infection during the second round and spreading infection in macrophages and other HIV-1 target cells. We have recently discovered that TET2 is a novel host factor degraded by Vpr, which leads to sustained IL-6 expression in macrophages. Interestingly, Vpr-enhanced HIV-1 Env processing depended on both the IFITIM3 and TET2 genes. The constitutive expression of IFITIM3 expression in macrophages was maintained by TET2, which demethylated the IFITIM3 promoter. We conclude that the Vpr degrades TET2 to enhance HIV-1 replication in macrophages by reducing IFITIM3 expression to increase viral Env processing, virion incorporation, and infectivity and by sustaining IL-6 expression to increase HIV-1 gene expression. The Vpr-TET2 axis may serve as a novel target to develop anti-HIV drugs to inhibit HIV-1 infection and pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“By targeting PU.1, Vpr systemically disrupted several antiviral factors, including MRC1, and IFITM3, a previously reported target of Vpr that is also capable of disrupting Env function38.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [38]
The cited source says what the claim attributes to it.
In the citing paper
“During HIV-1 infection of macrophages, in the absence of Vpr, TET2 demethylates the IFITM3 promoter, relieving suppression, contributing to the antiviral response.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [38]
The cited source says what the claim attributes to it.
In the citing paper
“Two of these genes, MRC1 and IFITM3, inhibit the spread of HIV in MDMs by targeting HIV-1 Env35,38.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [38]
The cited source says what the claim attributes to it.
In the citing paper
“IFITM3 expression is regulated by the DNA dioxygenase, TET238.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [38]
The cited source says what the claim attributes to it.
In the citing paper
“To prevent this, Vpr mediates the ubiquitylation and degradation of TET2, which in turn inhibits IFITM3 expression.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836 · cited 1×
“TET methylcytosine dioxygenases (TET1, -2, and -3 in mammalian cells [18, 19]) catalyze three steps of iterative oxidation, first converting 5mC to 5-hydroxymethyl cytosine (5hmC), then 5hmC to 5-formyl cytosine (5fC), and finally 5fC to 5-carboxy cytosine (5caC).”
Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine
Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., He, C., & Zhang, Y. (2011) · Science · doi:10.1126/science.1210597 · Cited by 3,451
DNA methylation landscapes: Provocative insights from epigenomics
Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039
The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain
Kriaucionis, S., & Heintz, N. (2009) · Science · doi:10.1126/science.1169786 · Cited by 2,700
HIV Infection, Inflammation, Immunosenescence, and Aging
Deeks, S. G. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-042909-093756 · Cited by 1,349
Connor, R. I., Chen, B. K., Choe, S., & Landau, N. R. (1995) · Virology · doi:10.1006/viro.1995.1016 · Cited by 1,253
Heinzinger, N. K., Bukinsky, M. I., Haggerty, S. A., Ragland, A. M., Kewalramani, V, Lee, M. A., Gendelman, H. E., Ratner, L., Stevenson, M., & Emerman, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7311 · Cited by 854 · cited 1×
“Although macrophages are relatively resistant to HIV-1 infection compared to activated CD4 T cells (2), HIV-1 has evolved to efficiently infect macrophages, which is enhanced by HIV-1 viral proteins such as viral protein R (Vpr) to counteract macrophage-specific restrictions (3, 4).”
The broad-spectrum antiviral functions of IFIT and IFITM proteins
Diamond, M. S., & Farzan, M. (2013) · Nature Reviews Immunology · doi:10.1038/nri3344 · Cited by 849
Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
Zhang, Q., Zhao, K., Shen, Q., Han, Y., Gu, Y., Li, X., Zhao, D., Liu, Y., Wang, C., Zhang, X., et al. (2015) · Nature · doi:10.1038/nature15252 · Cited by 807 · cited 12×
“The TET2-IFITM3 axis in MDMs thus suppresses HIV-1 replication both at the Env processing/virion infectivity step and possibly at the viral entry step in cells previously exposed to Vpr. IFITM3 expression is regulated by DNA methylation at the IFITM3 promoter (46).”
InfluentialIgarashi, T., Brown, C. R., Endo, Y., Buckler-White, A., Plishka, R., Bischofberger, N., Hirsch, V., & Martin, M. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.658 · Cited by 361
Cited by
Pharmacological perspectives and molecular mechanisms of coumarin derivatives against virus disease
Li, Z., Kong, D., Liu, Y., & Li, M. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.03.007 · Cited by 70
Vpr and Its Cellular Interaction Partners: R We There Yet?
Fábryová, H., & Strebel, K. (2019) · Cells · doi:10.3390/cells8111310 · Cited by 56
Wang, Y., Sholeh, M., Yang, L., Shakourzadeh, M. Z., Beig, M., & Azizian, K. (2025) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-025-01518-5 · Cited by 52
Macrophages: Key Cellular Players in HIV Infection and Pathogenesis
Woottum, M., Yan, S., Sayettat, S., Grinberg, S., Cathelin, D., Bekaddour, N., Herbeuval, J., & Bénichou, S. (2024) · Viruses · doi:10.3390/v16020288 · Cited by 42
Yu, Y., Yan, R., Chen, X., Sun, T., & Yan, J. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03865-w · Cited by 38
Deciphering DNA Methylation in HIV Infection
Arumugam, T., Ramphal, U., Adimulam, T., Chinniah, R., & Ramsuran, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.795121 · Cited by 36
Johnson, J. R., Crosby, D. C., Hultquist, J. F., Kurland, A. P., Adhikary, P., Li, D., Marlett, J. M., Swann, J., Hüttenhain, R., Verschueren, E., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110690 · Cited by 34
Nosik, M. N., Ryzhov, K., Rymanova, I., Sobkin, A., Kravtchenko, A., Kuimova, U., Pokrovsky, V. V., Зверев, В. В., & Свитич, О. А. (2021) · Microorganisms · doi:10.3390/microorganisms9112291 · Cited by 32
Host Restriction Factors Modulating HIV Latency and Replication in Macrophages
Pagani, I., Demela, P., Ghezzi, S., Vicenzi, E., Pizzato, M., & Poli, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063021 · Cited by 31
Vpr Is a VIP: HIV Vpr and Infected Macrophages Promote Viral Pathogenesis
Lubow, J., & Collins, K. L. (2020) · Viruses · doi:10.3390/v12080809 · Cited by 30
Epigenetic Landscape of HIV-1 Infection in Primary Human Macrophage
Lu, F. Y., Yi, Y., Vladimirova, O. V., Zankharia, U. S., Collman, R. G., & Lieberman, P. M. (2022) · Journal of Virology · doi:10.1128/jvi.00162-22 · Cited by 27
Virus-induced host genomic remodeling dysregulates gene expression, triggering tumorigenesis
Dong, W., Wang, H., Li, M., Li, P., & Ji, S. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1359766 · Cited by 24
Barbosa, J. A. F., Sparapani, S., Boulais, J., Lodge, R., & Cohen, É. A. (2021) · Journal of Virology · doi:10.1128/jvi.00971-20 · Cited by 16
HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages
Virgilio, M. C., Ramnani, B., Chen, T., Disbennett, W. M., Lubow, J., Welch, J. D., & Collins, K. L. (2024) · Nature Communications · doi:10.1038/s41467-024-49635-w · Cited by 14
“By targeting PU.1, Vpr systemically disrupted several antiviral factors, including MRC1 , and IFITM3 , a previously reported target of Vpr that is also capable of disrupting Env function 38 .”
InfluentialCRL4-DCAF1 Ubiquitin Ligase Dependent Functions of HIV Viral Protein R and Viral Protein X
Dobransky, A., Root, M., Hafner, N., Marcum, M., & Sharifi, H. J. (2024) · Viruses · doi:10.3390/v16081313 · Cited by 13
Hu, Y., Chen, X., Ling, Y., Zhou, K., Han, M., Wang, X., Yue, M., & Li, Y. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011550 · Cited by 13
Vpr driving DNA methylation variation of CD4 + T cells in HIV-1 infection
Wang, P., Meng, Z., Deng, K., Gao, Z., & Cai, J. (2024) · Virology Journal · doi:10.1186/s12985-024-02363-5 · Cited by 10
Human immunodeficiency virus-1 core: The Trojan horse in virus–host interaction
Wang, W., Li, Y., Zhang, Z., & Wei, W. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1002476 · Cited by 10
Chen, S., Wang, J., Wang, Q., Ping, Y., Yang, T., Ma, K., Pan, S., Bi, Y., Bai, H., & Chang, G. (2025) · Journal of Virology · doi:10.1128/jvi.02003-24 · Cited by 8
Self-citationMurray, D. D., Grund, B., MacPherson, C. R., Ekenberg, C., Zucco, A. G., Reekie, J., Domínguez, L., Leung, P., Fusco, D. N., Gras, J., et al. (2022) · AIDS · doi:10.1097/qad.0000000000003427 · Cited by 6
Duan, Y., Yuan, C. L., Suo, X., Cao, L., Kong, X., Li, X., Zheng, H., & Wang, Q. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27673 · Cited by 5
Self-citationToward the unveiling of HIV-1 dynamics: Involvement of monocytes/macrophages in HIV-1 infection
Sukegawa, S., & Takeuchi, H. (2022) · Frontiers in Virology · doi:10.3389/fviro.2022.934892 · Cited by 4
Huntingtin-Interacting Protein 1 Promotes Vpr-Induced G2 Arrest and HIV-1 Infection in Macrophages
Murakami, T., Matsuura, R., Chutiwitoonchai, N., Takei, M., & Aida, Y. (2021) · Viruses · doi:10.3390/v13112308 · Cited by 4
Interplay of swine acute diarrhoea syndrome coronavirus and the host intrinsic and innate immunity
Zhao, F., Cong, X., Huang, X., Zheng, Y., Zhao, Q., Wen, Y., Wu, R. J., Du, S., Cao, S., Cong, F., et al. (2025) · Veterinary Research · doi:10.1186/s13567-024-01436-1 · Cited by 3
Kouidou, S., Malousi, A., & Andreou, A. Z. (2020) · Pathogens · doi:10.3390/pathogens9121006 · Cited by 3
Poly (ADP-ribose) polymerase-1 regulates HIV-1 replication in human CD4+ T cellsPreprint
Martinez, Z. S., Gutiérrez, D. A., Valenzuela, C. A., Seong, C.-S., & Llano, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.11.598467 · Cited by 3
Chromatin remodeling by HIRA and FAS2 restricts geminivirus pathogenesis in plants
Sultana, S., Gupta, N., & Chakraborty, S. (2026) · Virology Journal · doi:10.1186/s12985-026-03068-7 · Cited by 2
TET2 ‐ CHIP : From Mutation to Malady
Jian, H., Sun, M., Xia, X., Su, C., Su, K., Xu, J. L., Yuan, Y., Li, C., Yu, M., & Cheng, X. (2026) · The FASEB Journal · doi:10.1096/fj.202600383r · Cited by 1
HIV-1 Vpr Degrades TET2 to Suppress IRF7 and Interferon Expression in Plasmacytoid Dendritic CellsPreprint
Wang, Q., Tsao, L.-C., Lv, L., Xu, Y., Cheng, L., Yu, H., Zhang, L., Xiong, Y., & Su, L. (2019) · SSRN Electronic Journal · doi:10.1101/823328
Self-citationWhole Genome Rare-Variant Association Study of HIV-1 Progression in a Southern African PopulationPreprint
Thami, P. K., Choga, W. T., Mulisa, D. D., Dandara, C., Shevchenko, A. K., Leteane, M. M., Novitsky, V., O’Brien, S. J., Essex, M., Gaseitsiwe, S., et al. (2020) · medRxiv · doi:10.1101/2020.12.16.20248307
Genetic diversity and population structure within Botswana: association with HIV-1 infection
Thami, P. K. (2021) · Open University of Cape Town (University of Cape Town)
Latence du VIH-1 et réplication des Coronavirus : nouvelles approches thérapeutiques.
Pasquereau, S. (2021) · theses.fr (ABES) · doi:10.70675/dd5c8432zc370z4e1ez9566z9f527aac2a6d
Role of coumarins in different infectious diseases
Hameed, S., Khan, K. M., & Solangi, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-15650-2.00009-x
Sithole, S. T., Ramsey, J. S., Call, M. C., Poole, B. D., Pickett, B. E., & Berges, B. K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.18.706531
Cantaloube-Ferrieu, V. (2023) · theses.fr (ABES) · doi:10.70675/e7422723z7cb9z4feczba3bz407046e4c995
Woottum, M. (2024) · theses.fr (ABES) · doi:10.70675/eb8f1671z3537z4850z9985z60ac5ec92890
The HIV-1 Vpr R77Q mutant alters host apoptotic gene regulation in CD4+ T cells
Sithole, S. T., Ramsey, J. S., Call, M. C., Ewool, K. K. K., Poole, B. D., Pickett, B. E., & Berges, B. K. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1830094
Zhang, H., Huang, P., Zhang, X., & Pan, T. S. (2026) · Viruses · doi:10.3390/v18080858
Metadata
- Authors
- Wang, Q., & Su, L.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Su, Lishan
- ORCID
- Su, Lishan
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2019-08-27
- Volume
- 10
- Issue
- 4
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- PMC
- PMC6703422
- OpenAlex
- W2969404469
- Cited by
- 34
- References
- 51
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 6 · 2023: 1 · 2022: 7 · 2021: 6 · 2020: 4 · 2019: 2
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mBio (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UNC Libraries
- Funders
- HHS | National Institutes of Health (AI127346, AI136990)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- HIV-1 Vpr, TET2, IFITM3, viral infectivity, macrophages, viral assembly, interleukin-6, promoter demethylation, host factors, HIV-1 replication, anti-HIV drug targets
- MeSH terms
- DNA Demethylation, Carrier Proteins, Cell Line, DNA-Binding Proteins, Humans, Macrophages, Membrane Proteins, Promoter Regions, Genetic, Proto-Oncogene Proteins, Virion, Virus Replication, HIV-1, Interleukin-6, Gene Expression Regulation, Viral, RNA-Binding Proteins, Anti-HIV Agents, Dioxygenases, env Gene Products, Human Immunodeficiency Virus, vpr Gene Products, Human Immunodeficiency Virus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.